Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
Phase 2
Withdrawn
- Conditions
- COVID-19 Acute Respiratory Distress SyndromeCOVID-19
- Interventions
- Other: Placebo
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- 4Living Biotech
- Registration Number
- NCT05411575
- Locations
- 🇧🇬
Multiprofile Hospital for Active Treatment AD Haskovo, Haskovo, Bulgaria
🇧🇬Multiprofile Hospital For Active Treatment Pazardzhik AD, Pazardzhik, Bulgaria
🇧🇬University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv, Bulgaria
News
No news found